Clinical Trial Update: Study to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAP [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on malaria vaccine candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP, and MVA ME-TRAP conducted by the Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• AdCh63 AMA1 (Chimpanzee adenovirus ChAd63 vector expressing AMA1)
• AdCh63 ME-TRAP (AdCh63 ME-TRAP)
• AdCh63 MSP1 (AdCh63 MSP1)
• MVA AMA1 (Modified vaccinia Ankara expressing AMA1)
• MVA ME-TRAP (MVA ME-TRAP)
• MVA MSP1 (MVA MSP1)

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED